Duchenne phenotype with in-frame deletion removing major portion of dystrophin rod: Threshold effect for deletion size?

被引:39
作者
Fanin, M
Freda, MP
Vitiello, L
Danieli, GA
Pegoraro, E
Angelini, C
机构
[1] UNIV PADUA,DEPT NEUROL,NEUROMUSC CTR,I-35128 PADUA,ITALY
[2] UNIV PADUA,DEPT BIOL,I-35128 PADUA,ITALY
关键词
in-frame deletion; Duchenne dystrophy; dystrophin; dystroglycan complex;
D O I
10.1002/mus.880190902
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
In a 9-year-old boy with Duchenne muscular dystrophy we found a large in-frame deletion, spanning exons 10 to 53 of the dystrophin gene, The deletion removed almost all of the central rod domain of dystrophin. Using carboxyterminal dystrophin antibodies the immunohistochemical reaction was normal in all muscle fibers, In immunoblot studies we found dystrophin of abnormal size (160 kDa) and normal amount (about 100%), The immunochemical features and the reading frame deduced from DNA analysis are usually associated wi ih Backer muscular dystrophy, but the clinical characteristics where those of the severe Duchenne phenotype, All the cases of in-frame dystrophin deletions reported so far, which involved more than 36 exons, invariably resulted in a severe phenotype. Therefore, a threshold effect for dystrophin length may be reasonably suspected. Very short dystrophin molecules might induce a severe disarray of the dystrophin network. (C) 1996 John Wiley & Sons, Inc.
引用
收藏
页码:1154 / 1160
页数:7
相关论文
共 43 条
[1]   THE FREQUENCY OF PATIENTS WITH DYSTROPHIN ABNORMALITIES IN A LIMB-GIRDLE PATIENT POPULATION [J].
ARIKAWA, E ;
HOFFMAN, EP ;
KAIDO, M ;
NONAKA, I ;
SUGITA, H ;
ARAHATA, K .
NEUROLOGY, 1991, 41 (09) :1491-1496
[2]   A SEVERE MUSCULAR-DYSTROPHY PATIENT WITH AN INTERNALLY DELETED VERY SHORT (110 KD) DYSTROPHIN - PRESENCE OF THE BINDING-SITE FOR DYSTROPHIN-ASSOCIATED GLYCOPROTEIN (DAG) MAY NOT BE ENOUGH FOR PHYSIOLOGICAL-FUNCTION OF DYSTROPHIN [J].
ARIKAWAHIRASAWA, E ;
KOGA, R ;
TSUKAHARA, T ;
NONAKA, I ;
MITSUDOME, A ;
GOTO, K ;
BEGGS, AH ;
ARAHATA, K .
NEUROMUSCULAR DISORDERS, 1995, 5 (05) :429-438
[3]  
BEGGS AH, 1991, AM J HUM GENET, V49, P54
[4]   SARCOLEMMAL EXPRESSION OF DYSTROPHIN C-TERMINUS BUT REDUCED EXPRESSION OF 6Q-DYSTROPHIN-RELATED PROTEIN IN 2 DMD PATIENTS WITH LARGE DELETIONS OF THE DYSTROPHIN GENE [J].
BITTNER, RE ;
SHORNY, S ;
FERLINGS, R ;
SPERL, W ;
KRESS, W ;
MULLER, CR ;
CREMER, M ;
LEGER, JJ ;
VOIT, T .
NEUROMUSCULAR DISORDERS, 1995, 5 (02) :81-92
[5]   THE CLINICAL, GENETIC AND DYSTROPHIN CHARACTERISTICS OF BECKER MUSCULAR-DYSTROPHY .2. CORRELATION OF PHENOTYPE WITH GENETIC AND PROTEIN ABNORMALITIES [J].
BUSHBY, KMD ;
GARDNERMEDWIN, D ;
NICHOLSON, LVB ;
JOHNSON, MA ;
HAGGERTY, ID ;
CLEGHORN, NJ ;
HARRIS, JB ;
BHATTACHARYA, SS .
JOURNAL OF NEUROLOGY, 1993, 240 (02) :105-112
[6]   GENETIC AND CLINICAL CORRELATIONS OF XP21 MUSCULAR-DYSTROPHY [J].
BUSHBY, KMD .
JOURNAL OF INHERITED METABOLIC DISEASE, 1992, 15 (04) :551-564
[7]   EFFECT OF DYSTROPHIN GENE DELETIONS ON MESSENGER-RNA LEVELS AND PROCESSING IN DUCHENNE AND BECKER MUSCULAR-DYSTROPHIES [J].
CHELLY, J ;
GILGENKRANTZ, H ;
LAMBERT, M ;
HAMARD, G ;
CHAFEY, P ;
RECAN, D ;
KATZ, P ;
DELACHAPELLE, A ;
KOENIG, M ;
GINJAAR, IB ;
FARDEAU, M ;
TOME, F ;
KAHN, A ;
KAPLAN, JC .
CELL, 1990, 63 (06) :1239-1248
[8]   CLINICAL VARIABILITY IN BECKER MUSCULAR-DYSTROPHY - GENETIC, BIOCHEMICAL AND IMMUNOHISTOCHEMICAL CORRELATES [J].
COMI, GP ;
PRELLE, A ;
BRESOLIN, N ;
MOGGIO, M ;
BARDONI, A ;
GALLANTI, A ;
VITA, G ;
TOSCANO, A ;
FERRO, MT ;
BORDONI, A ;
FORTUNATO, F ;
CISCATO, P ;
FELISARI, G ;
TEDESCHI, S ;
CASTELLI, E ;
GARGHENTINO, R ;
TURCONI, A ;
FRASCHINI, P ;
MARCHI, E ;
NEGRETTO, GG ;
ADOBBATI, L ;
MEOLA, G ;
TONIN, P ;
PAPADIMITRIOU, A ;
SCARLATO, G .
BRAIN, 1994, 117 :1-14
[9]  
CULLEN MJ, 1994, ACTA NEUROPATHOL, V87, P349
[10]  
DENDUNNEN JT, 1989, AM J HUM GENET, V45, P835